Skip to content

13F-HR filed by TAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-12, with 11 holding rows worth $26,564,014.

Accession
0001395064-25-000019
Filed
2025-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 12 entries on the cover page, a total value of $26,564,014 stated on the cover page (in dollars after the unit check, H1), rows summing to $26,564,014 with VALUE read as dollars as filed, 13F file number 028-24938. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerTakeda Vaccines, Inc.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HILLEVAX INC43157M102COM6,724,000$13,918,680dollars as filed
OVID THERAPEUTICS INC690469101COMMON STOCK7,531,996$7,011,884dollars as filed
Xilio Therapeutics Inc.98422T100COM1,475,121$1,416,116dollars as filed
EQUILLIUM INC29446K106COM1,824,977$1,368,733dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK515,619$623,899dollars as filed
AMERICAN WELL CORP03044L204COM CL A NEW77,733$563,564dollars as filed
LYELL IMMUNOPHARMA INC55083R104COM823,317$526,923dollars as filed
TURNSTONE BIOLOGICS CORP90042W100COM895,824$447,912dollars as filed
THIRD HARMONIC BIO INC88427A107COM36,835$379,032dollars as filed
RANI THERAPEUTICS HLDGS INC753018100CMN203,190$278,370dollars as filed
STANDARD BIOTOOLS INC34385P108COM16,515$28,901dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001395064-25-000019this filing2025-02-12acceptance time not in the bulk data set